The Globe and Mail
🏢 Globe and Mail Inc. (Woodbridge)
Jun 9, 2026
· 3 min read
AI Analyzed
○ Unverifiable
View full audit trail →
Apotex raising IPO size to $1.3-billion on strong investor demand, source says
Original article ↗ 🔒 Paywalled source — limited preview availableB.I.A.S. ANALYSIS
CENTER
LEFTCENTERRIGHT
Signal breakdown
Heuristic (v1/v3)
0.00 · CENTER
ML v2 (DistilBERT)
0.000 · CENTER
Ensemble
0.000 · CENTER
🏦 Source Intelligence
Rolling outlet bias
CENTER
avg -0.104
10,348 articles tracked
7-day bias trend
LcenterR
V.E.R.I.F.Y. has fact-checked this article.
Subscribe to see claim-by-claim verdicts and reasoning.
Subscribe to see claim-by-claim verdicts and reasoning.
Article Excerpt
Open this photo in gallery: Apotex workers walk through the company's grounds in Toronto in April, 2021. The company has priced the IPO deal at the top end of its marketing range, a source says. NATHAN DENETTE/THE CANADIAN PRESS COMMENTS SHARE SAVE FOR LATER Listen to this article Learn more about audio Log in or create a free account to listen to this article. Apotex Health Corp., Canada’s largest drug manufacturer, is increasing the size of its initial public offering to $1.3-billion on the back of strong investor demand and will price its shares at $24 each on the Toronto Stock Exchange. Th…
Read full article at The Globe and Mail ↗
How we scored this article
WTF uses a two-tier system: every article gets a heuristic bias score from keyword analysis, and priority articles (high overlap across 3+ outlets or strong heuristic signal) get full LLM analysis from B.I.A.S. and V.E.R.I.F.Y.
Analyzed by
B.I.A.S.
V.E.R.I.F.Y.
L.O.C.A.L.
quick v1
Jun 9, 2026